Itrafree 100mg Capsule contains Itraconazole, a broad-spectrum antifungal agent indicated for the treatment of various fungal infections. Itraconazole belongs to the triazole class of antifungals and exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. Itrafree is effective against infections caused by dermatophytes, yeasts, and molds, including conditions such as onychomycosis, blastomycosis, histoplasmosis, aspergillosis, and candidiasis. The capsule formulation allows for convenient oral administration with improved bioavailability when taken with food. Dosage and duration of therapy depend on the type and severity of infection, and treatment should be guided by clinical response and laboratory findings. Itrafree is contraindicated in patients with hypersensitivity to itraconazole or other azole antifungals and should be used cautiously in individuals with hepatic impairment or congestive heart failure. Common adverse effects include gastrointestinal disturbances, headache, and elevated liver enzymes. Drug interactions are significant due to itraconazole’s inhibition of cytochrome P450 3A4; therefore, concomitant use with certain medications requires careful monitoring. Itrafree 100mg Capsule should be prescribed and used under medical supervision to ensure safety and efficacy.